Status:
WITHDRAWN
Extended Treatment With Vancomycin for Clostridium Difficile Colitis
Lead Sponsor:
Corewell Health East
Collaborating Sponsors:
Beaumont Hospital
Conditions:
Clostridium Difficile Colitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
BACKGROUND: Clostridium difficile-associated colitis is an infection of the large bowel, usually associated with previous use of antibiotics. The disease course may be complicated by fulminant disease...
Detailed Description
METHODOLOGY: Patients with a first episode of Clostridium difficile colitis will be offered a prolonged course of Vancomycin. It will be disclosed that this is not the standard of care, but that a pro...
Eligibility Criteria
Inclusion
- First episode of Clostridium difficile colitis, defined by a positive toxin assay plus at least one of the following: diarrhea, toxic megacolon or leukocytosis.
Exclusion
- previous diagnosis of Clostridium difficile colitis
- concomitant use of oral Metronidazole, Rifampin, Rifaximin, Nitazoxanide, Sacharromyce boulardii or Lactobacillus spp.
- age less than 18 years-old
- pregnancy.
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00861887
Start Date
February 1 2009
End Date
January 1 2010
Last Update
December 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073